Use of low dose IL-2 for treating autoimmune related or inflammatory disorders
US10293028B2 · kind B2 · utility
19Cited by
2References
20Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | May 5, 2017 |
| Grant date | May 21, 2019 |
| Priority date | — |
| Expiry date | Jul 9, 2037 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to novel therapies for treating autoimmune and inflammatory diseases. More specifically, the present invention relates to a use of low dose interleukin-2 for the treatment of type I diabetes and other autoimmune and/or inflammatory diseases.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.